Plunkett Research Online: Galera Therapeutics Inc

GALERA THERAPEUTICS INC (GRTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM......


GALERA THERAPEUTICS INC

Ticker: GRTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 610 725-1500
Fax:
Address: 2 W Liberty Boulevard
Malvern, PA 19355 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

J. SorensenCEO/Director/President
Christopher DegnanCFO/Other Corporate Officer
See More
Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture